Chemists at Indiana University Bloomington have produced detailed
descriptions of the structure and molecular properties of human folate
receptor proteins, a key development for designing new drugs that can
target cancer and inflammatory diseases without serious side effects.
 |
| This image shows models of the human folate receptor (top) and antifolate drugs used in chemotherapy (bottom, from left: aminopterin, pemetrexed and methotrexate). (Credit: Charles Dann III / Courtesy of Indiana University) |
Credit: http://newsinfo.iu.edu